Literature DB >> 29193673

Ophthalmic features of cone-rod dystrophy caused by pathogenic variants in the ALMS1 gene.

Fadi Nasser1, Nicole Weisschuh2, Pietro Maffei3, Gabriella Milan3, Corina Heller4, Eberhart Zrenner1,5, Susanne Kohl2, Laura Kuehlewein1.   

Abstract

PURPOSE: We aim to describe ophthalmic characteristics and systemic findings in a cohort of seven patients with cone-rod retinal dystrophy (CORD) caused by pathogenic variants in the ALMS1 gene.
METHODS: Seven patients with Alström syndrome (ALMS) were included in the study. A comprehensive ophthalmological examination was performed, including best-corrected visual acuity (BCVA), a semiautomated kinetic visual field exam, colour vision testing, full-field electroretinography testing according to International Society for Clinical Electrophysiology of Vision (ISCEV) standards, spectral domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) imaging, and slit lamp and dilated fundus examination. DNA samples were analysed using Sanger sequencing or exome sequencing.
RESULTS: In our cohort, the ocular phenotype presented with a wide variability in retinal function and disease severity. However, age of symptom onset (i.e. nystagmus and photophobia) was at 6-9 months in all patients. These symptoms mostly mislead to the diagnosis of congenital achromatopsia (ACHM), Leber congenital amaurosis (LCA), isolated CORD or Bardet-Biedl syndrome. The systemic manifestations in our cohort were highly variable.
CONCLUSION: In summary, we can report that most of our ALMS patients primarily presented with nystagmus and severe photophobia since early childhood interestingly without night blindness in the absence of systemic symptoms. Only genetic testing analysing both nonsyndromic retinal disease (RD) genes and syndromic ciliopathy genes by comprehensive panel sequencing can result in the correct diagnosis, genetically and clinically, with important implication for the physical health of the individual.
© 2017 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ALMS1; Alström Syndrome; Cone-rod dystrophy; hereditary retinal degeneration

Mesh:

Substances:

Year:  2017        PMID: 29193673     DOI: 10.1111/aos.13612

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  9 in total

1.  Reliability of Semiautomated Kinetic Perimetry (SKP) and Goldmann Kinetic Perimetry in Children and Adults With Retinal Dystrophies.

Authors:  Claire S Barnes; Ronald A Schuchard; David G Birch; Gislin Dagnelie; Leah Wood; Robert K Koenekoop; Ava K Bittner
Journal:  Transl Vis Sci Technol       Date:  2019-06-11       Impact factor: 3.283

2.  Clinical characteristics of individual organ system disease in non-motile ciliopathies.

Authors:  Angela Grochowsky; Meral Gunay-Aygun
Journal:  Transl Sci Rare Dis       Date:  2019-07-04

3.  A case report of two siblings with Alstrom syndrome without hearing loss associated with two new ALMS1 variants.

Authors:  Maria F Shurygina; Maria A Parker; Catie L Schlechter; Rui Chen; Yumei Li; Richard G Weleber; Paul Yang; Mark E Pennesi
Journal:  BMC Ophthalmol       Date:  2019-12-07       Impact factor: 2.209

4.  Ocular evaluation and genetic test for an early Alström Syndrome diagnosis.

Authors:  Tyler Etheridge; Elizabeth R Kellom; Rachel Sullivan; James N Ver Hoeve; Melanie A Schmitt
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-12

5.  Neovascularization of the optic disc and peripheral retinal ischemia in a child with a novel variant in ALMS1 (Alström syndrome).

Authors:  Melinda Y Chang; Mark S Borchert; Ryan Schmidt; Aaron Nagiel
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-25

6.  Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome.

Authors:  Luca Marozio; Francesca Dassie; Gianluca Bertschy; Emilie M Canuto; Gabriella Milan; Stefano Cosma; Pietro Maffei; Chiara Benedetto
Journal:  Front Genet       Date:  2022-10-03       Impact factor: 4.772

7.  New pathogenic variants of ALMS1 gene in two Chinese families with Alström Syndrome.

Authors:  Wan-Yu Cheng; Mei-Jiao Ma; Shi-Qin Yuan; Xiao-Long Qi; Wei-Ning Rong; Xun-Lun Sheng
Journal:  BMC Ophthalmol       Date:  2022-09-26       Impact factor: 2.086

8.  Bardet-Biedl syndrome-7 (BBS7) shows treatment potential and a cone-rod dystrophy phenotype that recapitulates the non-human primate model.

Authors:  Tomas S Aleman; Erin C O'Neil; Keli O'Connor; Yu You Jiang; Isabella A Aleman; Jean Bennett; Jessica I W Morgan; Brian W Toussaint
Journal:  Ophthalmic Genet       Date:  2021-03-17       Impact factor: 1.274

9.  Consensus clinical management guidelines for Alström syndrome.

Authors:  Natascia Tahani; Pietro Maffei; Hélène Dollfus; Richard Paisey; Diana Valverde; Gabriella Milan; Joan C Han; Francesca Favaretto; Shyam C Madathil; Charlotte Dawson; Matthew J Armstrong; Adrian T Warfield; Selma Düzenli; Clair A Francomano; Meral Gunay-Aygun; Francesca Dassie; Vincent Marion; Marina Valenti; Kerry Leeson-Beevers; Ann Chivers; Richard Steeds; Timothy Barrett; Tarekegn Geberhiwot
Journal:  Orphanet J Rare Dis       Date:  2020-09-21       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.